DarukaMahadevanMD
Oncology • San Antonio, TXAssociate Professor, Medicine, University of Arizona College of Medicine
Dr. Mahadevan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
7979 Wurzbach Road
San Antonio, TX 78229Phone+1 210-450-1143Fax+1 210-450-0407- Is this information wrong?
Education & Training
University of Arizona College of Medicine-TucsonFellowship, Hematology and Medical Oncology, 2000 - 2002
University of ConnecticutResidency, Internal Medicine, 1994 - 1997
Guy's, King's and St Thomas' School of Medical EducationClass of 1990
Certifications & Licensure
TX State Medical License 2020 - 2025
AZ State Medical License 2002 - 2021
TN State Medical License 2012 - 2017
MS State Medical License 2013 - 2016
CT State Medical License 1998 - 2003- American Board of Internal Medicine Medical Oncology
Clinical Trials
- S0350 Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Peripheral T-Cell Non-Hodgkin's Lymphoma Start of enrollment: 2005 Sep 01
- Study to Assess the Safety of Escalating Doses of AT13387 in Patients With Metastatic Solid Tumors Start of enrollment: 2008 May 01
- Study of PWT33597 Mesylate in Subjects With Advanced Malignancies Start of enrollment: 2011 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- Polyploidy in Cancer: causal mechanisms, cancer-specific consequences, and emerging treatments.Conway, P., Dao, J., Kovalskyy, D., Mahadevan, D., Dray, E.> ;Molecular Cancer Therapeutics. 2024 Feb 5
- (HER2) amplifications and co-occurringalterations in the circulating cell-free DNA of pancreatic ductal adenocarcinoma patients and response to HER2 inhibition.Weipert, C., Espenschied, C., Raymond, V., Gordon, E., Barzi, A., Wang-Gillam, A., Nezami, M., Mahadevan, D., Mody, K.> ;Frontiers in Oncology. 2024 Jan 1
- Advancing Inclusive Research (AIR) Site Alliance: Facilitating the inclusion of historically underrepresented people in oncology and ophthalmology clinical research.Vidal, G., Chalela, P., Curry, A., El-Rayes, B., Halmos, B., Herrera, A., Kapoor, K., Kaur, S., Mahadevan, D., Mesa, R., Ramirez, A., Sleckman, B., Wagner, A., Bhagat,...> ;Contemporary Clinical Trials. 2024 Feb 1
- Join now to see all
Journal Articles
- Abemaciclib in Combination with Single-Agent Options in Patients with Stage IV Non-Small Cell Lung Cancer: A Phase 1b StudyKaren Kelly, Montaser Shaheen, Shadia Jalal, Daruka Mahadevan, Clinical Cancer Research
- Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/vincristine in Relapsed/refractory Aggressive B-cell LymphomaDaniel Persky, Soham Puvvada, Catherine Spier, Gregory Monohan, Ari VanderWalde, Daruka Mahadevan, Clinical Cancer Research
Press Mentions
Researchers Look to Bring New Blood Tests for Cancer to MarketMay 26th, 2019
Immunotherapy—Cancer's New FrontierApril 5th, 2018
Professional Memberships
- Member
Hospital Affiliations
University Health / UT Health Science Center at San AntonioSan Antonio, Texas- University Health / UT Health Science Center at San AntonioSan Antonio, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
